XML 22 R10.htm IDEA: XBRL DOCUMENT
v3.25.2

Segments | 6 Months Ended
--- | ---
Jun. 30, 2025
Segments [Abstract] |
Segments | 3. Segments Our segments include the VITAS segment and the Roto-Rooter segment, which comprise the structure used by our President and Chief Executive Officer, who has been determined to be our Chief Operating Decision Maker (“CODM”) to make key operating decisions and assess performance. Relative contributions of each segment to service revenues and sales for the second quarter of 2025 were 64% and 36% compared to the second quarter of 2024 were 63% and 37%. Relative contributions of each segment to service revenues and sales for the first six months of 2025 were 63% and 37% compared to the first six months of 2024 were 61% and 39%. The vast majority of our service revenues and sales from continuing operations are generated from business within the United States. Service revenues and sales by business segment are shown in Note 2. The reportable segments have been defined along service lines, which is consistent with the way the businesses are managed. In determining reportable segments, the RRSC and RRC operating units of the Roto-Rooter segment have been aggregated on the basis of possessing similar operating and economic characteristics. The characteristics of these operating segments and the basis for aggregation are reviewed annually. We report corporate administrative expenses and unallocated investing and financing income and expense not directly related to either segment as “Corporate”. Corporate administrative expense includes the stewardship, accounting and reporting, legal, tax and other costs of operating a publicly held corporation. Corporate investing and financing income and expenses include the costs and income associated with corporate debt and investment arrangements. Our CODM evaluates the segments’ operating performance based mainly on income/(loss) from operations. For each segment, the CODM compares segment income/(loss) from operations in the annual budgeting and monthly forecasting process to actual results. The CODM considers variances on a monthly basis for evaluating performance of each segment and making decisions about allocating resources to each segment. ‎ Segment data for the three months ending June 30, 2025 are as follows (in thousands):
|  |  |  |  |  |  |  | Reportable |  |  |  |  | Chemed
|  | VITAS |  | Roto-Rooter |  | Segments |  | Corporate |  | Consolidated
Service revenues and sales |  | $ | 396,201 |  | $ | 222,597 |  | $ | 618,798 |  | $ | - |  | $ | 618,798
Cost of services provided and goods sold |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
(excluding depreciation) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Wages |  |  | 241,805 |  |  | 75,704 |  |  | 317,509 |  |  | - |  |  | 317,509
Patient care expense |  |  | 41,008 |  |  | - |  |  | 41,008 |  |  | - |  |  | 41,008
Other expenses |  |  | 37,831 |  |  | 37,757 |  |  | 75,588 |  |  | - |  |  | 75,588
Total cost of services provided and goods sold |  |  | 320,644 |  |  | 113,461 |  |  | 434,105 |  |  | - |  |  | 434,105
Selling, general and administrative expense |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Wages |  |  | 16,757 |  |  | 21,018 |  |  | 37,775 |  |  | 2,748 |  |  | 40,523
Advertising |  |  | - |  |  | 18,943 |  |  | 18,943 |  |  | - |  |  | 18,943
Stock compensation |  |  | - |  |  | - |  |  | - |  |  | 10,069 |  |  | 10,069
Other expenses |  |  | 8,328 |  |  | 20,575 |  |  | 28,903 |  |  | 1,885 |  |  | 30,788
Total selling, general and administrative expense |  |  | 25,085 |  |  | 60,536 |  |  | 85,621 |  |  | 14,702 |  |  | 100,323
Depreciation |  |  | 5,314 |  |  | 8,363 |  |  | 13,677 |  |  | 12 |  |  | 13,689
Amortization |  |  | 26 |  |  | 2,545 |  |  | 2,571 |  |  | - |  |  | 2,571
Other operating expense/(income) |  |  | 55 |  |  | (29) |  |  | 26 |  |  | - |  |  | 26
Total costs and expenses |  |  | 351,124 |  |  | 184,876 |  |  | 536,000 |  |  | 14,714 |  |  | 550,714
Income/(loss) from operations |  |  | 45,077 |  |  | 37,721 |  |  | 82,798 |  |  | (14,714) |  |  | 68,084
Interest expense |  |  | (47) |  |  | (129) |  |  | (176) |  |  | (267) |  |  | (443)
Intercompany interest income/(expense) |  |  | 5,454 |  |  | 3,970 |  |  | 9,424 |  |  | (9,424) |  |  | -
Other income - net |  |  | 61 |  |  | 23 |  |  | 84 |  |  | 3,390 |  |  | 3,474
Income/(expense) before income taxes |  |  | 50,545 |  |  | 41,585 |  |  | 92,130 |  |  | (21,015) |  |  | 71,115
Income taxes |  |  | (12,326) |  |  | (9,671) |  |  | (21,997) |  |  | 3,375 |  |  | (18,622)
Net income/(loss) |  | $ | 38,219 |  | $ | 31,914 |  | $ | 70,133 |  | $ | (17,640) |  | $ | 52,493
Additions to long-lived assets |  | $ | 7,060 |  | $ | 8,745 |  | $ | 15,805 |  | $ | 5 |  | $ | 15,810
‎ Segment data for the three months ending June 30, 2024 are as follows (in thousands):
|  |  |  |  |  |  |  | Reportable |  |  |  |  | Chemed
|  | VITAS |  | Roto-Rooter |  | Segments |  | Corporate |  | Consolidated
Service revenues and sales |  | $ | 374,558 |  | $ | 221,322 |  | $ | 595,880 |  | $ | - |  | $ | 595,880
Cost of services provided and goods sold |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
(excluding depreciation) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Wages |  |  | 212,811 |  |  | 73,057 |  |  | 285,868 |  |  | - |  |  | 285,868
Patient care expense |  |  | 36,625 |  |  | - |  |  | 36,625 |  |  | - |  |  | 36,625
Other expenses |  |  | 36,081 |  |  | 31,176 |  |  | 67,257 |  |  | - |  |  | 67,257
Total cost of services provided and good sold |  |  | 285,517 |  |  | 104,233 |  |  | 389,750 |  |  | - |  |  | 389,750
Selling, general and administrative expense |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Wages |  |  | 17,369 |  |  | 20,002 |  |  | 37,371 |  |  | 4,367 |  |  | 41,738
Advertising |  |  | - |  |  | 17,327 |  |  | 17,327 |  |  | - |  |  | 17,327
Stock compensation |  |  | - |  |  | - |  |  | - |  |  | 12,463 |  |  | 12,463
Other expenses |  |  | 6,924 |  |  | 20,022 |  |  | 26,946 |  |  | 3,781 |  |  | 30,727
Total selling, general and administrative expense |  |  | 24,293 |  |  | 57,351 |  |  | 81,644 |  |  | 20,611 |  |  | 102,255
Depreciation |  |  | 5,058 |  |  | 8,096 |  |  | 13,154 |  |  | 13 |  |  | 13,167
Amortization |  |  | 26 |  |  | 2,520 |  |  | 2,546 |  |  | - |  |  | 2,546
Other operating expense/(income) |  |  | 56 |  |  | (19) |  |  | 37 |  |  | - |  |  | 37
Total costs and expenses |  |  | 314,950 |  |  | 172,181 |  |  | 487,131 |  |  | 20,624 |  |  | 507,755
Income/(loss) from operations |  |  | 59,608 |  |  | 49,141 |  |  | 108,749 |  |  | (20,624) |  |  | 88,125
Interest expense |  |  | (46) |  |  | (118) |  |  | (164) |  |  | (265) |  |  | (429)
Intercompany interest income/(expense) |  |  | 4,982 |  |  | 3,540 |  |  | 8,522 |  |  | (8,522) |  |  | -
Other income - net |  |  | 46 |  |  | 24 |  |  | 70 |  |  | 6,062 |  |  | 6,132
Income/(expense) before income taxes |  |  | 64,590 |  |  | 52,587 |  |  | 117,177 |  |  | (23,349) |  |  | 93,828
Income taxes |  |  | (15,338) |  |  | (12,070) |  |  | (27,408) |  |  | 4,467 |  |  | (22,941)
Net income/(loss) |  | $ | 49,252 |  | $ | 40,517 |  | $ | 89,769 |  | $ | (18,882) |  | $ | 70,887
Additions to long-lived assets |  | $ | 90,714 |  | $ | 5,552 |  | $ | 96,266 |  | $ | 164 |  | $ | 96,430
‎ Segment data for the first six months ending June 30, 2025 are as follows (in thousands):
|  |  |  |  |  |  |  | Reportable |  |  |  |  | Chemed
|  | VITAS |  | Roto-Rooter |  | Segments |  | Corporate |  | Consolidated
Service revenues and sales |  | $ | 803,600 |  | $ | 462,141 |  | $ | 1,265,741 |  | $ | - |  | $ | 1,265,741
Cost of services provided and goods sold |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
(excluding depreciation) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Wages |  |  | 476,978 |  |  | 153,176 |  |  | 630,154 |  |  | - |  |  | 630,154
Patient care expense |  |  | 81,387 |  |  | - |  |  | 81,387 |  |  | - |  |  | 81,387
Other expenses |  |  | 75,086 |  |  | 78,008 |  |  | 153,094 |  |  | - |  |  | 153,094
Total cost of services provided and goods sold |  |  | 633,451 |  |  | 231,184 |  |  | 864,635 |  |  | - |  |  | 864,635
Selling, general and administrative expense |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Wages |  |  | 34,284 |  |  | 42,204 |  |  | 76,488 |  |  | 7,479 |  |  | 83,967
Advertising |  |  | - |  |  | 37,112 |  |  | 37,112 |  |  | - |  |  | 37,112
Stock compensation |  |  | - |  |  | - |  |  | - |  |  | 21,817 |  |  | 21,817
Other expenses |  |  | 17,340 |  |  | 43,868 |  |  | 61,208 |  |  | 1,806 |  |  | 63,014
Total selling, general and administrative expense |  |  | 51,624 |  |  | 123,184 |  |  | 174,808 |  |  | 31,102 |  |  | 205,910
Depreciation |  |  | 10,509 |  |  | 16,601 |  |  | 27,110 |  |  | 24 |  |  | 27,134
Amortization |  |  | 52 |  |  | 5,091 |  |  | 5,143 |  |  | - |  |  | 5,143
Other operating expense/(income) |  |  | 119 |  |  | (42) |  |  | 77 |  |  | - |  |  | 77
Total costs and expenses |  |  | 695,755 |  |  | 376,018 |  |  | 1,071,773 |  |  | 31,126 |  |  | 1,102,899
Income/(loss) from operations |  |  | 107,845 |  |  | 86,123 |  |  | 193,968 |  |  | (31,126) |  |  | 162,842
Interest expense |  |  | (95) |  |  | (261) |  |  | (356) |  |  | (416) |  |  | (772)
Intercompany interest income/(expense) |  |  | 10,750 |  |  | 7,900 |  |  | 18,650 |  |  | (18,650) |  |  | -
Other income - net |  |  | 110 |  |  | 32 |  |  | 142 |  |  | 4,577 |  |  | 4,719
Income/(expense) before income taxes |  |  | 118,610 |  |  | 93,794 |  |  | 212,404 |  |  | (45,615) |  |  | 166,789
Income taxes |  |  | (30,361) |  |  | (21,936) |  |  | (52,297) |  |  | 9,758 |  |  | (42,539)
Net income/(loss) |  | $ | 88,249 |  | $ | 71,858 |  | $ | 160,107 |  | $ | (35,857) |  | $ | 124,250
Additions to long-lived assets |  | $ | 11,384 |  | $ | 18,186 |  | $ | 29,570 |  | $ | 5 |  | $ | 29,575
‎ Segment data for the first six months ending June 30, 2024 are as follows (in thousands):
|  |  |  |  |  |  |  | Reportable |  |  |  |  | Chemed
|  | VITAS |  | Roto-Rooter |  | Segments |  | Corporate |  | Consolidated
Service revenues and sales |  | $ | 728,564 |  | $ | 456,549 |  | $ | 1,185,113 |  | $ | - |  | $ | 1,185,113
Cost of services provided and goods sold |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
(excluding depreciation) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Wages |  |  | 416,235 |  |  | 151,591 |  |  | 567,826 |  |  | - |  |  | 567,826
Patient care expense |  |  | 71,699 |  |  | - |  |  | 71,699 |  |  | - |  |  | 71,699
Other expenses |  |  | 69,477 |  |  | 65,875 |  |  | 135,352 |  |  | - |  |  | 135,352
Total cost of services provided and goods sold |  |  | 557,411 |  |  | 217,466 |  |  | 774,877 |  |  | - |  |  | 774,877
Selling, general and administrative expense |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Wages |  |  | 33,898 |  |  | 41,077 |  |  | 74,975 |  |  | 8,307 |  |  | 83,282
Advertising |  |  | - |  |  | 36,851 |  |  | 36,851 |  |  | - |  |  | 36,851
Stock compensation |  |  | - |  |  | - |  |  | - |  |  | 30,609 |  |  | 30,609
Other expenses |  |  | 14,187 |  |  | 40,683 |  |  | 54,870 |  |  | 12,516 |  |  | 67,386
Total selling, general and administrative expense |  |  | 48,085 |  |  | 118,611 |  |  | 166,696 |  |  | 51,432 |  |  | 218,128
Depreciation |  |  | 10,225 |  |  | 16,204 |  |  | 26,429 |  |  | 25 |  |  | 26,454
Amortization |  |  | 52 |  |  | 5,015 |  |  | 5,067 |  |  | - |  |  | 5,067
Other operating expense |  |  | 63 |  |  | 66 |  |  | 129 |  |  | - |  |  | 129
Total costs and expenses |  |  | 615,836 |  |  | 357,362 |  |  | 973,198 |  |  | 51,457 |  |  | 1,024,655
Income/(loss) from operations |  |  | 112,728 |  |  | 99,187 |  |  | 211,915 |  |  | (51,457) |  |  | 160,458
Interest expense |  |  | (92) |  |  | (235) |  |  | (327) |  |  | (527) |  |  | (854)
Intercompany interest income/(expense) |  |  | 10,176 |  |  | 6,982 |  |  | 17,158 |  |  | (17,158) |  |  | -
Other income - net |  |  | 75 |  |  | 47 |  |  | 122 |  |  | 18,587 |  |  | 18,709
Income/(expense) before income taxes |  |  | 122,887 |  |  | 105,981 |  |  | 228,868 |  |  | (50,555) |  |  | 178,313
Income taxes |  |  | (29,666) |  |  | (24,610) |  |  | (54,276) |  |  | 11,867 |  |  | (42,409)
Net income/(loss) |  | $ | 93,221 |  | $ | 81,371 |  | $ | 174,592 |  | $ | (38,688) |  | $ | 135,904
Additions to long-lived assets |  | $ | 96,569 |  | $ | 19,022 |  | $ | 115,591 |  | $ | 171 |  | $ | 115,762
Identifiable assets by segment are as follows (in thousands)::
| June 30, |  | December 31,
| 2025 |  | 2024
VITAS | $ | 781,617 |  | $ | 839,568
Roto-Rooter |  | 543,950 |  |  | 529,076
Reportable segments |  | 1,325,567 |  |  | 1,368,644
Corporate |  | 392,280 |  |  | 299,931
Chemed consolidated | $ | 1,717,847 |  | $ | 1,668,575

X
- References No definition available. + Details
Name: | us-gaap_SegmentReportingAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments. + References Reference 1: http://www.xbrl.org/2003/role/exampleRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 48 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 32 -Subparagraph (f) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 270 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (i) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 32 -Subparagraph (ee) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32 Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 32 -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32 Reference 6: http://www.xbrl.org/2003/role/exampleRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 54 -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54 Reference 7: http://www.xbrl.org/2003/role/exampleRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 47 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47 Reference 8: http://www.xbrl.org/2003/role/exampleRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 54 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54 Reference 9: http://www.xbrl.org/2003/role/exampleRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 47 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47 Reference 10: http://www.xbrl.org/2003/role/exampleRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 54 -Subparagraph (e) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54 Reference 11: http://www.xbrl.org/2003/role/exampleRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 47 -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47 Reference 12: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 22 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22 Reference 13: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 31 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31 Reference 14: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 34 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-34 Reference 15: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 26C -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26C Reference 16: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 26B -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26B Reference 17: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 15 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-15 Reference 18: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 42 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42 Reference 19: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 40 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-40 Reference 20: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/280/tableOfContent Reference 21: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 26 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26 Reference 22: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 41 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41 Reference 23: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 21 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-21 Reference 24: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 21 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-21 Reference 25: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 32 -Subparagraph (e) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32 + Details
Name: | us-gaap_SegmentReportingDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration